kylie @kylie@mastodon.grimerica.ca
Novel Antibody Therapies Market Research Report by 2022, Forecast till 2035
Given the potential of novel antibody therapies in the treatment of oncological disorders, there is a growing interest in evaluating such therapy candidates against other life-threatening disease indications as well
For more information, please click on the following link:
https://www.rootsanalysis.com/reports/novel-antibody-therapies-market.html
The global monkeypox therapeutics and vaccines market and global monkeypox diagnostic kits market is likely to grow at a healthy pace in the foreseen future, claims Roots Analysis
The recent rise in the incidence of the monkeypox disease, also known as Mpox, has compelled both industry players and regional government authorities to undertake active initiatives in order to control the spread of the disease
For additional details, please visit https://www.rootsanalysis.com/reports/monkeypox-treatment-market.html
Long-acting drug delivery technologies and services
For additional details, please visit
https://www.rootsanalysis.com/reports/long-acting-drug-delivery-market.html or email sales@rootsanalysis.com
Driven by the growing demand for medical devices, novel coatings providing unique features are being introduced in the market
For additional
details, please visit https://www.rootsanalysis.com/reports/medical-device-coatings-market.html or email sales@rootsanalysis.com
The mRNA synthesis and manufacturing market is projected to be worth USD 1.5 billion by 2035, claims Roots Analysis
Given the current technical and operational challenges associated with the manufacturing of mRNA-based products, innovators in the biopharmaceutical industry are increasingly relying on the mRNA synthesis and contract manufacturing service providers.
For additional details, please visit
https://www.rootsanalysis.com/reports/mrna-synthesis-and-manufacturing-market.html or email sales@rootsanalysis.com
The SARM1 targeting therapeutics market is projected to grow at a CAGR of 102.1%, during the period 2033-2040, claims Roots Analysis
SARM1 inhibitors, having demonstrated the ability to prevent axonal degeneration, are being evaluated for the treatment of a number of neurodegenerative disorders. Once approved, these therapies are likely to capture a significant market share
For additional details, please visit
https://www.rootsanalysis.com/reports/sarm1-inhibitors-market.html
or email sales@rootsanalysis.com
